share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144：擬議出售證券
美股sec公告 ·  05/30 23:53
牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 2,350 shares of common stock on 05/30/2024, with an aggregate market value of approximately $1,031,908. The shares were acquired on 02/24/2024 as part of a restricted stock vesting, which was a compensation-related transaction from the issuer. There have been no other securities sold by Tatsis in the past three months prior to the notice date of the planned sale.
Vertex Pharmaceuticals Inc. officer Ourania Tatsis is set to sell 2,350 shares of common stock on 05/30/2024, with an aggregate market value of approximately $1,031,908. The shares were acquired on 02/24/2024 as part of a restricted stock vesting, which was a compensation-related transaction from the issuer. There have been no other securities sold by Tatsis in the past three months prior to the notice date of the planned sale.
Vertex Pharmicals Inc.高管歐拉尼亞·塔西斯定於2024年5月30日出售2350股普通股，總市值約爲1,031,908美元。這些股票於2024年2月24日作爲限制性股票歸屬的一部分收購，這是發行人與薪酬相關的交易。在計劃出售的通知日期之前的過去三個月中，塔西斯沒有出售其他證券。
Vertex Pharmicals Inc.高管歐拉尼亞·塔西斯定於2024年5月30日出售2350股普通股，總市值約爲1,031,908美元。這些股票於2024年2月24日作爲限制性股票歸屬的一部分收購，這是發行人與薪酬相關的交易。在計劃出售的通知日期之前的過去三個月中，塔西斯沒有出售其他證券。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。